Soligenix Inc (SNGX)
3.62
+0.02
(+0.56%)
USD |
NASDAQ |
Nov 05, 16:00
3.62
0.00 (0.00%)
After-Hours: 16:07
Soligenix Research and Development Expense (Annual): 3.313M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.313M |
| December 31, 2022 | 7.944M |
| December 31, 2021 | 8.186M |
| December 31, 2020 | 14.80M |
| December 31, 2019 | 8.123M |
| December 31, 2018 | 6.751M |
| December 31, 2017 | 5.507M |
| December 31, 2016 | 4.296M |
| December 31, 2015 | 5.400M |
| December 31, 2014 | 5.086M |
| December 31, 2013 | 5.071M |
| December 31, 2012 | 2.609M |
| December 31, 2011 | 6.273M |
| December 31, 2010 | 5.986M |
| Date | Value |
|---|---|
| December 31, 2009 | 4.523M |
| December 31, 2008 | 1.552M |
| December 31, 2007 | 3.100M |
| December 31, 2006 | 4.620M |
| December 31, 2005 | 3.681M |
| December 31, 2004 | 3.657M |
| December 31, 2003 | 2.729M |
| December 31, 2002 | 2.944M |
| December 31, 2001 | 2.471M |
| December 31, 2000 | 0.9567M |
| December 31, 1999 | 2.029M |
| December 31, 1998 | 3.10M |
| December 31, 1997 | 1.80M |
| January 31, 1996 | 0.9065M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.313M
Minimum
2023
14.80M
Maximum
2020
8.472M
Average
8.123M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 86.66M |
| Lixte Biotechnology Holdings Inc | 0.8981M |
| Shuttle Pharmaceuticals Holdings Inc | 3.517M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.40M |